Published in Gene Therapy Weekly, June 14th, 1999
According to a report in the journal Molecular Cell, published May 20, 1999, ARF normally prevents cellular transformation by preventing degradation of the p53 protein. It allows p53 to accumulate in the cell's nucleus where it functions to stop tumor cell growth.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.